•   
  •   

World Pakistanis join final trials for China-made vaccine

14:50  26 november  2020
14:50  26 november  2020 Source:   msn.com

The next huge challenge for a Covid-19 vaccine: Keeping it extremely cold

  The next huge challenge for a Covid-19 vaccine: Keeping it extremely cold Pfizer and BioNTech’s Covid-19 vaccine needs to be stored at minus 70 degrees Celsius. Is that a deal breaker?But the vaccine’s potential to provide immunity to the broader population is now threatened by a massive logistical hurdle in actually getting it to people safely: keeping the vaccine doses very, very cold.

"Successful clinical trial in Pakistan will make it one of the first few countries for launch of a Covid-19 According to Dr Ikram, the benefit from the clinical trials being held in Pakistan will be that if the Test the vaccine on Pakistanis and if they turn out to be safe start vaccinating people in China .

Chinese developer of coronavirus vaccine secures approval for final stage of human trials . A Chinese state-owned vaccine developer secured regulatory approval to test its coronavirus shots in the United Arab Emirates, making it one of the first among a slew of global efforts to get the greenlight for

Thousands of volunteers are flocking to research hospitals across Pakistan to join final-stage clinical trials of a Chinese-made vaccine for the coronavirus.

a group of people standing next to a sign: Thousands of Pakistanis have volunteered to take part in the final-stage trial of a Chinese vaccine for Covid-19 © Aamir QURESHI Thousands of Pakistanis have volunteered to take part in the final-stage trial of a Chinese vaccine for Covid-19

It is the first time Pakistan has participated in such a trial, which comes amid a string of positive vaccine announcements by Western pharmaceutical companies this month.

a group of people in a room: Pakistan has already inoculated about 7,000 of the 10,000 participants expected to receive a jab © Aamir QURESHI Pakistan has already inoculated about 7,000 of the 10,000 participants expected to receive a jab

The vaccine is being developed by CanSinoBio and the Beijing Institute of Biotechnology China.

The ethics of deliberately infecting volunteers with Covid-19 to test vaccines

  The ethics of deliberately infecting volunteers with Covid-19 to test vaccines Scientists will soon launch a “human challenge trial.” Here’s why that’s so controversial.They’re young. They’re healthy. And they want scientists to give them a candidate vaccine and then deliberately expose them to the coronavirus, so we can all find out faster whether the vaccine is effective.

Trials of a coronavirus vaccine are set to take place in the UAE after an agreement was reached with a Chinese medical firm. If successful, the Phase III trial could result in the vaccine going on to be produced on a large scale within the Emirates. The initiative is a partnership between China National

Three Chinese - made vaccines purported to be safe and effective against Covid-19 have made their debut at a local trade fair, the first to be held for. Sinovac said that the final human trial for its vaccine is being conducted in Brazil and Indonesia, with an eye towards a year-end launch for the

"I have volunteered myself for a noble cause that will help humanity," said a volunteer at Islamabad's Shifa hospital, where hundreds of participants are being paid about $50 for their trouble.

text, letter: Volunteers are paid $50 for taking part in the vaccine trial, which researchers hope will produce findings on its efficacy in two to three months © Aamir QURESHI Volunteers are paid $50 for taking part in the vaccine trial, which researchers hope will produce findings on its efficacy in two to three months

Others should "step forward and take part in this noble cause which will save lives," he added.

For years, China has focused much of its attention in Pakistan on mammoth development projects, bankrolling the construction of roads, power plants and a strategic port.


Video: Covid-19 ICU in New Delhi as city struggles to keep up with virus cases (AFP)

Beijing has now tapped one of its closest allies to participate in the vaccine trials, despite Pakistan's chequered history with inoculation campaigns.

Pfizer’s Covid-19 vaccine just came a little closer to emergency approval

  Pfizer’s Covid-19 vaccine just came a little closer to emergency approval Pfizer and BioNTech now say their vaccine is 95 percent effective and has cleared its trial benchmarks.A press release out Wednesday from the two companies reports the results of 170 Covid-19 cases confirmed in their clinical trial pool: Eight in the group that received the vaccine got Covid-19 versus 162 in the placebo group, demonstrating an efficacy of 95 percent.

China said on Friday it has joined a global Covid-19 vaccine initiative co-led by the World Health Organization, becoming the biggest economy to date China has at least four experimental vaccines in the final stage of clinical trials – two are developed by state-backed China National Biotec Group

A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market A state-owned drugmaker that has a dominant share of China ’s vaccine market, CNBG in April was among the world’s first to push experimental shots to the crucial final stage of human testing.

"We hope to have some findings ready about the accuracy and efficacy of the vaccine in two to three months," Ejaz Ahmad Khan, the principal researcher overseeing the trial in Pakistan, told AFP.

Officials said Pakistan has already inoculated about 7,000 of the 10,000 participants expected to receive a jab.

The trials come with intensive care wards across the country nearing capacity as a second, deadlier wave of the coronavirus spreads and officials struggle to counter public indifference to the pandemic.

The country has confirmed more than 382,000 cases including over 7,800 deaths since the virus arrived in late February.

Less than a year after the coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising Covid-19 vaccines are on the cusp of release.

Four separate drug makers have recently announced that their vaccines are effective for most people.

Due to lingering suspicions over vaccines, Pakistan is one of just two countries where polio continues to spread, sparking fears that a new drive to inoculate the population against the coronavirus will fail.

The Chinese vaccine is also undergoing phase 3 trials -- or large-scale testing on humans -- in several other nations including China, Russia, Chile, Argentina and Saudi Arabia.

jaf/ds/wat/mtp

Moderna's groundbreaking coronavirus vaccine was designed in just 2 days .
Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19, according to the company. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days. In contrast, traditional vaccines can take years to design. Visit Business Insider's homepage for more stories. Moderna's coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials, the company announced last week.

usr: 3
This is interesting!